We are delighted to announce the appointment of Dr. Dean Regier as Associate Director for the Academy of Translational Medicine (ATM).
Dr. Regier is an associate professor at the School of Population and Public Health and a Senior Scientist at the BC Cancer Research Institute. He also serves on B.C.’s Drug Benefit Council, which makes evidence-informed recommendations to the Ministry of Health about which drugs to cover under the provincial PharmaCare program.
As the previous Co-Director pro tem of the ATM, and the current Chair of the ATM Regulatory Advisory Council, Dr. Regier has comprehensive knowledge of the ATM organization and ongoing initiatives. As Associate Director of the ATM, Dr. Regier will assist and support the Director with strategic direction and decision-making related to the ATM.
Dr. Regier says: “I’m delighted to be named Associate Director of the ATM. The ambitious goal of the ATM is to halve the time it takes for new, effective health products to reach patients. To achieve this, we are seeking to establish the ATM as a world-leading centre of excellence. Over the past year, we have worked to realize our goals through engaging with and building a multi-disciplinary community, and through creating micro-certificate training programs in regulatory science and entrepreneurship.” Dr Regier goes on to say “My next steps with the ATM include working to build infrastructure at UBC and in BC’s health care system to further the generation of evidence for patient and public health”.
Please join us in congratulating Dr. Regier on his appointment.